The Meaning of the 11% Credit Rate
"Post-2030, the Arizona R&D credit rate on expenses over $2.5M drops from 15% to 11%. This 4% reduction fundamentally alters the ROI for large-scale innovation projects."
A detailed analysis of A.R.S. § 43-1168, the looming statutory cliff, and what it means for your tax strategy.
Financial Impact Calculator
Estimate the credit value gap between Current Law and Post-2030 Law.
Impact Summary
Projected Credit Value Drop-off
Context & Scope
The Arizona Research and Development (R&D) tax credit is a critical incentive for innovation. Historically, the state has offered one of the most generous non-refundable (and partially refundable) credits in the nation.
However, the statute governing this credit, A.R.S. § 43-1168, contains provisions that significantly alter the rate structure for taxable years beginning from and after December 31, 2030. Understanding the "11% rate" requires analyzing the two-tiered calculation method.
Key Statistics
-
1
Current Tier 1 Rate
24%
First $2.5M in QREs
-
2
Post-2030 Tier 2 Rate
11%
Expenses over $2.5M (Down from 15%)
The "11% Meaning" Deconstructed
The "11% Credit Rate" is not a flat rate applied to all expenses. It is the specific marginal rate applied to excess Qualified Research Expenses (QREs) in the post-2030 era. This creates a significant "cliff" for large companies heavily investing in Arizona.
| Expense Tier (QRE) | Current Rate (Pre-2031) | Post-2030 Rate | Change |
|---|---|---|---|
| First $2,500,000 | 24% | 20% | -4% |
| Amounts over $2,500,000 | 15% | 11% | -4% |
Note: This rate reduction applies to both the non-refundable credit and the calculation basis for the refundable portion (which is capped at 75% of the calculated credit).
Local Revenue Office Guidance
Applying the law requires strict adherence to Arizona Department of Revenue (ADOR) procedures.
Form 308: Calculating the Credit
Taxpayers must use Arizona Form 308 to calculate the credit. The form allows for the input of QREs and applies the tiered rates automatically.
Guidance: For years starting after 12/31/2030, Form 308 instructions will be updated to reflect the 20%/11% rates. Taxpayers cannot use prior year forms for post-2030 filings.
Carryover Provisions
If the credit exceeds taxes owed, the unused portion may be carried forward for 15 consecutive taxable years.
Strategy: Credits generated at the higher (24%/15%) rates before 2031 retain their value when carried forward. The rate change affects the generation of new credits, not the usage of old ones.
Refundability (ACA Certification)
To claim a refund (instead of carryover), you must obtain a Certificate of Qualification from the Arizona Commerce Authority (ACA).
Impact: The refund is capped at 75% of the calculated credit. With the post-2030 rate drop to 11% on excess, the maximum refundable cash value drops proportionally.
Combined Returns (Form 120)
Corporate partners apply their share of the credit on Form 120. The definition of QREs follows the Internal Revenue Code § 41.
Note: While federal R&D laws change frequently, Arizona's "piggyback" on the federal definition of QREs remains constant, but the rate applied to those QREs is state-specific.
Strategic Conclusion
The drop to an 11% credit rate for excess spending post-2030 is not a minor adjustment—it is a significant fiscal contraction. Businesses with long-term R&D horizons extending into the next decade should accelerate expenses into the pre-2031 window where possible to capture the 15% rate, or lobby for legislative extension of current incentives.
Arizona R&D Tax Credit Forecast: Strategic Implications of the Scheduled Shift to the 11% Rate Post-2030
The 11% credit rate represents the reduced marginal non-refundable tax incentive applied to Qualified Research Expenses (QREs) exceeding the statutory threshold of $2.5 million for tax years beginning after December 31, 2030. This scheduled decrease, mandated by Arizona Revised Statutes (A.R.S.) § 43-1168, is a critical factor for long-term corporate financial modeling and marks a significant depreciation of the incentive value for businesses engaged in large-scale research and development within the state.
I. Foundations of the Arizona R&D Tax Credit (A.R.S. § 43-1168)
The Arizona Research and Development (R&D) Tax Credit is a vital component of the state’s strategy to stimulate economic growth, particularly within high-value sectors such as technology, aerospace, biotechnology, and manufacturing.1 Enacted in 1994 and continually updated, the primary statutory authority for the corporate non-refundable credit is found in A.R.S. § 43-1168.
Statutory Authority and Purpose
The primary goal of this credit is to incentivize businesses to increase their investment in qualified research activities within Arizona.2 The credit is non-refundable, meaning it is applied directly against the taxpayer’s Arizona income tax liability, although a limited refundable component exists for qualified small businesses, administered separately.3
Federal Alignment via IRC § 41
Arizona’s R&D credit computation leverages the fundamental definitions and methodology established at the federal level under Internal Revenue Code (IRC) Section 41.4 The calculation of the credit is based on the concept of increased research activity. Specifically, the credit is computed based on the sum of current year Qualified Research Expenses (QREs) and basic research payments that exceed a defined “base amount”.4 This methodology ensures that the incentive is directed towards incremental research investment rather than maintaining baseline activities.
Arizona’s Unique Base Period Calculation
Although the credit leverages the framework of IRC § 41, Arizona mandates a critical deviation regarding the calculation of the “base amount” for taxpayers. The base amount, a key limiter on the credit size, is calculated using a fixed-base percentage (a ratio of prior QREs to gross receipts). State guidance, such as that provided in the instructions for Arizona Form 308, specifies that taxpayers must use Arizona-specific QREs and Arizona gross receipts, rather than federal, nation-wide amounts.6
This state-specific calculation is a deliberate policy design aimed at maximizing the credit benefit for multi-state corporations. For a national company conducting R&D in Arizona but realizing the majority of its sales volume outside the state, using only Arizona gross receipts in the denominator of the fixed-base percentage calculation results in a lower overall base percentage. A lower fixed-base percentage, in turn, yields a smaller base amount. By shrinking the base amount, the pool of “Excess QREs”—the amount eligible for the credit—is consequently maximized. This structural mechanism demonstrates the state’s aggressive effort to draw and retain significant R&D investment, prioritizing in-state research activity over a taxpayer’s national market share.
Furthermore, the state provides specific rules for new companies. Startups benefit from a fixed-base percentage of 3% during their first five taxable years, phasing up to a maximum of 16% by the tenth year, easing the initial compliance burden and enhancing early-stage credit capture.1
II. The Legislative Context: Extension and Statutory Sunset
The present-day structure of the Arizona R&D credit, specifically the high 24% and 15% tiered rates, is not permanent. The 11% rate is the result of a statutory sunset provision that was previously delayed by legislative action. Understanding this history is crucial for projecting long-term tax liability.
Current Credit Rates Extended Through 2030
The prevailing non-refundable credit rates, applicable until the end of Tax Year (TY) 2030, are tiered:
- Tier 1: 24% of the first $2.5 million of excess Qualified Research Expenses (QREs).1
- Tier 2 (Marginal Rate): 15% of the excess QREs above $2.5 million.1
The Delay of the Rate Reduction
The transition to the lower rates of 20% and 11% was originally scheduled to commence much earlier, specifically beginning in Tax Year 2022.9 However, the Arizona legislature passed measures, such as the House Engrossed version of HB 2771, which successfully extended the higher 24% and 15% corporate credit rates through TY 2030. This legislative intervention explicitly delayed the implementation of the lower corporate credit rates—20% on the first $2.5 million and 11% on amounts above—until Tax Year 2031.9
The fiscal assessment of this delay confirmed that extending the higher rates meant the state’s General Fund would forgo any potential revenue gain that would have materialized had the rates been permitted to drop beginning in 2022.9 The statutory effective date for the reduction is now explicitly defined as “For taxable years beginning from and after December 31, 2030”.4
Policy Rationale for Extension and Reduction
The decision to delay the reduction, while still maintaining a scheduled cut in 2031, suggests a clear tension in state policy. Annual reports on R&D spending indicated that Arizona’s share of national R&D expenditure and its ranking among states had gradually declined between 2015 and 2020, dropping from 18th to 21st place nationally.10 The maintenance of the higher, more generous tax incentive rates for nearly a decade (2022–2030) served as a competitive tool designed to counteract this declining national trend and stabilize or grow the state’s R&D base.
However, the statutory schedule confirms the 2031 reduction remains codified. This structural arrangement compels long-term tax strategists to operate under the assumption that the 11% rate will apply, necessitating adjustments to financial forecasts. The scheduled reduction may suggest that lawmakers anticipate sufficient growth in the state’s R&D sector by 2031 to absorb a significant decrease in the tax incentive, or alternatively, that they expect to revisit and potentially extend the current, higher rates again closer to the deadline. Prudent tax planning must currently assume the codified reduction will occur.
III. Statutory Analysis of the Post-2030 Credit Structure
The transition to the 11% rate is governed by the specific provisions of A.R.S. § 43-1168(A)(1). This shift is not a simple reduction but a precisely calibrated adjustment to the tiered formula.
A.R.S. § 43-1168(A)(1): The Formulaic Breakdown
The statutory formula for computing the credit post-2030 is defined across two tiers, based on the total calculated excess QREs (the sum of qualified research expenses and basic research payments over the base amount):
1. Tier 1 Reduction: 24% to 20%
For the first $2,500,000 of the calculated sum, the credit rate is reduced from 24% to 20%.4 This is articulated in A.R.S. § 43-1168(A)(1)(b)(ii).
2. Tier 2 Marginal Rate: The 11% Provision
If the total calculated sum is over $2,500,000, the formula changes, and this is where the 11% rate takes effect. A.R.S. § 43-1168(A)(1)(c)(ii) explicitly states that for taxable years beginning from and after December 31, 2030, the credit is equal to “$500,000 plus eleven percent of any amount exceeding $2,500,000”.4
Interpreting the $500,000 Fixed Component
The fixed credit component of $500,000 is directly derived from the reduced Tier 1 rate. It represents the maximum credit generated on the first $2.5 million of excess QREs when calculated at the new 20% rate $(\$2,500,000 \times 20\% = \$500,000)$.5
For comparison, under the current regime (pre-2031), the fixed credit amount is $600,000 $(\$2,500,000 \times 24\% = \$600,000)$.5 This coordinated reduction in both the fixed component and the marginal rate ensures a continuous and linear incentive structure, maintaining the tiered system without any computational breaks at the $2.5 million threshold. This structural consistency confirms that the 11% rate is not an isolated adjustment but part of a systematic, phased plan for general reduction in corporate R&D tax relief.
The Impact of the Rate Differential
The reduction from 15% to 11% on marginal QREs above the threshold represents a substantial decrease in the state’s incentive value. This 4-percentage-point decline translates into a 26.7% reduction in the credit generated for every dollar spent beyond $2.5 million. This loss fundamentally alters the return on investment for long-term, high-volume R&D expenditures in Arizona, making such projects financially more demanding in the post-2030 environment.11
It should be noted that the reduction to the 11% marginal rate does not affect the separate additional credit available for basic research payments made to universities under the Arizona Board of Regents (such as Northern Arizona University, the University of Arizona, or Arizona State University). That supplemental non-refundable credit remains at 10% of those excess payments.2
IV. State Administrative Guidance and Compliance Requirements
The administration of the Arizona R&D tax credit is bifurcated, involving both the Arizona Department of Revenue (ADOR) and the Arizona Commerce Authority (ACA).
A. The Role of the Arizona Department of Revenue (ADOR)
The ADOR is the governing body for the primary non-refundable corporate and individual R&D credit (A.R.S. § 43-1168).2 All taxpayers claiming the non-refundable credit must submit detailed calculations using the appropriate tax forms, such as Form 308-I for corporate taxpayers.7 This form requires the meticulous computation of the qualified research expenses, the calculation of the base amount using Arizona-specific gross receipts, and the determination of the resulting credit percentage based on the applicable statutory rates (24%/15% until 2030, and 20%/11% thereafter).
Reduced Carryforward Period and Utilization Challenges
An essential administrative change impacting the utility of the credit, regardless of the rate, is the carryforward period. For credits generated beginning in Tax Year 2022, the carryforward period for unused non-refundable credit amounts was reduced from 15 years to 10 consecutive taxable years.9
This accelerated expiration schedule requires sophisticated tax planning. The corporate carryforward balance for R&D credits was substantial, reported at $1.5 billion in Tax Year 2021.10 The reduction in the carryforward period necessitates that large corporations rapidly move toward profitability to utilize their existing, higher-value credits before they expire. This pairing of a reduced utilization timeframe with the scheduled post-2030 rate decrease creates an accelerated mandate for R&D firms to reach a taxable position, effectively placing an indirect limitation on the long-term, speculative research projects characteristic of pre-profit startups.
B. The Role of the Arizona Commerce Authority (ACA)
The ACA administers the distinct refundable component of the R&D credit program (A.R.S. § 41-1507), which aims to provide immediate cash benefit to qualified small businesses.2
Refundable Credit Structure and Limits
Eligibility for a refund is strictly limited to companies that meet the non-refundable credit qualifications and employ fewer than 150 full-time employees.3 Key parameters of the refundable program include:
- Refund Amount: The refundable portion is 75% of the excess credit (the current year’s credit less the current year’s tax liability), with the remaining 25% of the excess credit being forfeited if a refund is claimed.5
- Per-Taxpayer Cap: Refunds are capped at $100,000 per taxpayer annually.1
- Statewide Cap: The aggregate annual statewide cap on refundable credits was recently increased from $5 million to $10 million.1 However, even the former $5 million cap was often exceeded; in Tax Year 2022, applications totaled nearly $6.8 million.3
- Certification Requirement: To receive a refund, taxpayers must apply to and receive a Certificate of Qualification from the ACA before filing their tax return with ADOR.5
Because the refundable option is generally only utilized by small businesses, which are unlikely to generate the volume of QREs necessary to exceed the $2.5 million threshold, the 11% marginal rate is typically a non-factor for this subset of taxpayers. Their primary concern is the Tier 1 rate reduction from 24% to 20% post-2030.
V. Strategic Impact and Quantifying the Rate Differential
The most crucial aspect of the 11% rate is its quantitative financial impact on corporate tax strategy. The reduction is not merely academic; it translates directly into hundreds of thousands, or millions, of dollars in foregone tax benefits for large-scale R&D investors.
The following table summarizes the mandatory statutory rate changes effective for tax years beginning after December 31, 2030, as mandated by A.R.S. § 43-1168(A)(1).
Table 1: Arizona R&D Tax Credit Rate Comparison (Pre-2031 vs. Post-2030)
| Excess QRE Threshold | Rate Before Dec. 31, 2030 (24%/15%) | Fixed Credit at $2.5M | Rate After Dec. 31, 2030 (20%/11%) | Fixed Credit at $2.5M |
| $\leq \$2.5$ Million | 24% of amount | N/A | 20% of amount | N/A |
| $>\$2.5$ Million (Marginal Rate) | 15% of excess amount | $600,000 | 11% of excess amount | $500,000 |
Scenario Modeling: Quantifying the Loss
To illustrate the exact financial consequence of the rate change, consider a large corporation generating $12.5 million in calculated Excess QREs:
- Credit Calculation Pre-2031 (24%/15% Rates):
- Credit on the first $2.5M: $24\% \times \$2,500,000 = \$600,000$
- Excess QREs subject to 15% marginal rate: $\$12,500,000 – \$2,500,000 = \$10,000,000$
- Credit on excess: $15\% \times \$10,000,000 = \$1,500,000$
- Total Credit Pre-2031: $\$600,000 + \$1,500,000 = \$2,100,000$
- Credit Calculation Post-2030 (20%/11% Rates):
- Credit on the first $2.5M: $20\% \times \$2,500,000 = \$500,000$
- Excess QREs subject to 11% marginal rate: $\$10,000,000$
- Credit on excess: $11\% \times \$10,000,000 = \$1,100,000$
- Total Credit Post-2030: $\$500,000 + \$1,100,000 = \$1,600,000$
Financial Differential: The scheduled rate reduction results in a loss of $500,000 in tax credit value for this level of R&D investment. This represents a 23.8% reduction in the total credit benefit, proving that the statutory change is financially severe for companies with large R&D platforms.
This substantial depreciation in incentive value necessitates a crucial strategic review of multi-state QRE allocation. Corporations with operations across several states that offer R&D tax incentives must use this future depreciation data to model the long-term profitability of allocating research personnel and capital within Arizona versus other jurisdictions that may offer stable or growing incentives. The known, scheduled 24% depreciation in Arizona’s incentive starting in 2031 creates an immediate competitive disadvantage in attracting future long-range capital projects.
VI. Practical Calculation Example: Applying the 11% Rate in Tax Year 2031
This section provides a detailed, step-by-step example demonstrating the application of the statutory formula (A.R.S. § 43-1168(A)(1)(c)(ii)) for a high-volume taxpayer in the post-2030 environment.
Scenario Setup
AZ Tech Innovations, a corporate taxpayer, begins its taxable year on January 1, 2031. After computing the required base amount pursuant to IRC § 41(c) and A.R.S. § 43-1168, the company determines its combined Excess QREs plus basic research payments for the year total $15,000,000.
Step 1: Determine Statutory Tiers and Rates (Post-2030)
For taxable years beginning after December 31, 2030, the tiered structure is:
- Tier 1 (Up to $2,500,000): 20%
- Tier 2 (Amount exceeding $2,500,000): 11%
Step 2: Calculate Tier 1 Credit (Fixed Component)
The credit on the first $2.5 million of excess QREs is calculated at the Tier 1 rate of 20%:
$$\$2,500,000 \times 20\% = \$500,000$$
Step 3: Calculate Excess QREs Subject to the Marginal Rate
The total amount of Excess QREs is $15,000,000. The portion subject to the marginal 11% rate is the amount above the Tier 1 threshold:
$$\$15,000,000 – \$2,500,000 = \$12,500,000$$
Step 4: Apply the 11% Marginal Rate (Tier 2 Credit)
The credit on the remaining $12,500,000 is calculated at the Tier 2 rate of 11%:
$$\$12,500,000 \times 11\% = \$1,375,000$$
Step 5: Calculate Total Non-Refundable Credit (TY 2031)
The total non-refundable R&D credit is the sum of the Tier 1 and Tier 2 credits:
$$\$500,000 + \$1,375,000 = \$1,875,000$$
Table 2: Hypothetical R&D Credit Calculation (Post-2031 Scenario – $15M Excess QREs)
| Calculation Component | Formula Reference (Post-2031) | Value | Credit Generated |
| Assumed Total Excess QREs | N/A | $15,000,000 | N/A |
| Tier 1 Calculation (Up to $2.5M) | A.R.S. § 43-1168(A)(1)(b)(ii) | $20\% \times \$2,500,000$ | $500,000 |
| Tier 2 Calculation (Amount > $2.5M) | A.R.S. § 43-1168(A)(1)(c)(ii) | $11\% \times \$12,500,000$ | $1,375,000 |
| Total Non-Refundable Credit (TY 2031) | Tier 1 Credit + Tier 2 Credit | N/A | $1,875,000 |
This calculated total of $1,875,000 confirms the statutory formula and demonstrates that the marginal 11% rate directly limits the overall benefit for high-expenditure taxpayers. For the same $15 million investment, the taxpayer would have claimed $2,475,000 had the 15% marginal rate been in effect.
VII. Conclusion: Future Tax Planning for Arizona R&D
The analysis of A.R.S. § 43-1168 confirms that the transition to the 20%/11% tiered credit structure is currently a statutory certainty for taxable years beginning on or after January 1, 2031. This change has profound implications for long-term tax strategy and capital allocation decisions within the R&D sector.
The most severe impact is the nearly 25% depreciation in the overall credit value for companies exceeding the $2.5 million threshold, resulting from the shift from a 15% to an 11% marginal rate. This reduction necessitates immediate adjustments to project profitability models and internal rates of return (IRR) for any Arizona-based R&D initiatives scheduled to extend beyond 2030.
Furthermore, the simultaneous reduction of the carryforward period from 15 years to 10 years for new credits created after Tax Year 2021 significantly accelerates the utilization pressure on taxpayers. Given the pre-existing $1.5 billion corporate carryforward balance, this decreased carryforward period, coupled with the future rate reduction, indicates a policy shift towards prioritizing immediate, profitable R&D over speculative, decade-long research endeavors.
Actionable Recommendations for Tax Strategy
- Mandatory Budgetary Realignment: Corporate R&D budgets and capital expenditure forecasts must incorporate the 11% marginal credit rate to accurately reflect the true post-tax cost of research activities starting in 2031. Failing to model this scheduled decrease will lead to overestimation of future tax savings.
- Accelerated Utilization Strategy: Tax departments must prioritize the utilization of existing, higher-value credits (generated at the 24%/15% rates) within the new 10-year expiration window to prevent the forfeiture of accrued tax benefits.
Legislative Monitoring and Advocacy: Since the 2031 reduction represents a significant loss of state competitiveness for attracting major R&D investment, affected corporations should actively monitor legislative developments. The historical success of delaying the rate cuts (e.g., HB 2771) suggests the possibility of future legislative intervention to extend the current 24%/15% rates beyond the current 2030 sunset date. Strategic planning, however, must assume the 11% rate applies until a formal extension is enacted.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
